Current state of the use of sonographic contrast agents with low acoustic pressure techniques in the study of focal liver lesions;Stato attuale dell'impiego dei mezzi di contrasto ecografici con tecnica a bassa pressione acustica nello studio delle lesioni focali epatiche

Radiologia Medica

Volumn 107, Issue 3, 2004, Pages 174-188

  Borghi, Claudia ^a   Aiani, Luca ^a   Sopransi, Marco ^a   Belloni, Gianmarco ^a   Martegani, Alberto ^a  

^a VALDUCE HOSPITAL   (Italy)

Author keywords

Liver; Sonographic contrast agents; Ultrasound

Indexed keywords

ECHO CONTRAST MEDIUM; FS 069; SONOVUE;

ADENOMA; B SCAN; BILE DUCT CARCINOMA; CANCER SCREENING; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; HEMODYNAMICS; HEPATITIS C VIRUS; HUMAN; IMAGING; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMANGIOMA; LIVER HEMATOMA; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; NODULAR HYPERPLASIA; REVIEW; STEATOSIS;

ALBUMINS; ALGORITHMS; CONTRAST MEDIA; FLUOROCARBONS; HEMODYNAMIC PROCESSES; HUMANS; LIVER DISEASES; PHOSPHOLIPIDS; PHYSICS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 1842812022     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Hagspiel KD, Neidl KFW, Eichenberger AC et al: Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196: 471-478, 1995.
2. Heiken JP, Weyman PJ, Lee JKT et al: Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography and MRI. Radiology 171: 47-52, 1989.
3. Hollett MD, Jeffrey RB, Nino-Murcia M et al: Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (less than 1.5 cm) malignant hepatic neoplasms. AJR 164: 879-884, 1995.
4. Van Beers BE, Gallez B, Pringot J: Contrast-enhanced MR imaging of the liver. Radiology 203: 297-306, 1997.
5. Van Leeuwen MS, Noordzij J, Feldberg MAM et al: Focal liver lesions: characterization with triphasic spiral CT. Radiology 201: 327-336, 1996.
6. De Gaetano AM, Barbaro B, Chiara C et al: The tissue characterization of focal liver lesions by color Doppler echography. Radiol Med 89:453-463, 1995.
7. Elias D, Leclere J, Lasser PH et al: Surgical interventions for erroneous diagnoses of liver metastases. Ann Chir 48: 332-338, 1994.
8. Lencioni R, Pinto F, Armillotta N et al: Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 201: 353-359, 1996.
9. Nino-Murcia M, Ralls PW, Jeffrey RB et al: Color flow Doppler characterization of focal hepatic lesions. AJR 159: 1195-1197, 1992.
10. Strunk H, Stuckmann G, Frohlich et al: Native and signal-enhanced power Doppler sonography for characterization of liver lesions. Rofo 168: 344-351, 1998.
11. Tanaka S, Kitamura T, Numata K: Color Doppler flow imaging of liver tumors. AJR 154: 509-514, 1990.
12. Schneider M, Arditi M, Barrau MB et al: BR1: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol 30: 451-457, 1995.
13. Schneider M: Characteristics of SonoVue. Echocardiography: A Jrnl of CV Ultrasound and Allied Tech. Vol. 16, N. 7, Part 2: 743-746, 1999.
14. Mattrey RF, Pelura TJ: Perfluorocarbon-based ultrasound contrast agents. In: Goldberg BB (ed): Ultrasound contrast agents, pag. 83-87. Martin Dunits, 1997.
15. Morel DR, Schwieger I, Hohn L et al: Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35: 80-85, 2000.
16. Soman P, Lahiri A, Senior R: The safety of intravenous SonoVue, a second generation contrast agent for echocardiography in patients with several left ventricle dysfunction. Heart in press.
17. Burns PN, Powers JE, Simpson DH, et al: Harmonic imaging with ultrasound contrast agents. Clin Radiol 51: 50-55, 1996.
18. Del Favero C, Martegani A, Aiani L et al: Liver imaging: to break or not to break the microbubbles? Syllabus "Bubbles in Radiology - the State of the Art". The Second Symposium on Ultrasound Contrast for Radiological Diagnosis 44-51; Oct 22-23, 2000, Toronto, Canada.
19. Goldberg BB, Liu JB, Forsberg F: Ultrasound contrast agents: review. Ultrasound Med Biol 20: 319-333, 1994.
20. Von Bibra H, Voigt JV, Froman M et al: Interaction of microbubbles with ultrasound echocardiography. A Jrnl of CV Ultrasound and Allied Tech, Vol 16, N. 7, Part 2, 1999.
21. Kono Y, Moriyasu F, Mine Y: Grayscale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol 32: 120-125, 1997.
22. Harvey CJ, Pilcher JM, Eckersley RJ et al: Advances in ultrasound. Clin Radiol 57: 157-77, 2002.
23. Leen E: The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 11: E27-34, 2001.
24. Bernatik T, Strobel D, Hahn EG et al: Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. Ultrasound Med 20: 509-15, 2001.
25. Bauer A, Blombey M, Leen E et al: Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 9: S349-52, 1999.
26. Bertolotto M, Dalla Palma L, Quaia E et al: Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10: 1369-1376, 2000.
27. Blomely MJK, Albrecht T, Cosgrove DO: Improved imaging of liver metastases using stimulated acoustic emission in the late phase of enhancement with US contrast agent SHU 563 A: early experience. Radiology 210: 409-416, 1999.
28. Burns PN, Wilson SR, Simpson DH: Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35: 58-71, 2000.
29. Giovagnoni A, Martegani A, Aiani L et al: Pulse inversion US with echographic contrast media (Levovist) in the evaluation of hepatic metastases. Radiol Med 101: 111-117, 2001.
30. Harvey CJ, Blomely MJK, Eckersley H et al: Hepatic malignancies: improved detection with pulse inversion US in late phase with SHU 508 A; early experience. Radiology 216: 903-908, 2000.
31. Jang HJ, Lim HK, Lee WJ et al: Ultrasonographic evaluation of focal hepatic lesions: comparison of pulse inversion harmonic, and conventional imaging techniques. J Ultrasound Med 19:293-299; quiz 301-302, 2000.
32. Wilson SR, Burns PN, Muradali D et al: Harmonic hepatic US with micro-bubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 215: 153-161, 2000.
33. Kim TK, Choi BI, Han JK et al: Hepatic tumors: contrast agent enhancement patterns with pulse inversion harmonic US. Radiology 216: 411-417, 2000.
34. Leen E, Angerson WJ, Yarmenitis S et al: Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41: 200-206, 2002.
35. Basilico R, Blomley MJ, Harvey CJ et al: Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radiol 41:184-191, 2002.